CollPlant Biotechnologies (CollPlant Biotechnologies) EV-to-Revenue : 4.00 (As of May. 01, 2024)

View and export this data going back to 2021. Start your Free Trial

What is CollPlant Biotechnologies EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, CollPlant Biotechnologies's enterprise value is $43.84 Mil. CollPlant Biotechnologies's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $10.96 Mil. Therefore, CollPlant Biotechnologies's EV-to-Revenue for today is 4.00.

The historical rank and industry rank for CollPlant Biotechnologies's EV-to-Revenue or its related term are showing as below:

CLGN' s EV-to-Revenue Range Over the Past 10 Years
Min: 2.98 Med: 8.24 Max: 396.01
Current: 4

During the past 12 years, the highest EV-to-Revenue of CollPlant Biotechnologies was 396.01. The lowest was 2.98. And the median was 8.24.

CLGN's EV-to-Revenue is ranked better than
64.89% of 1031 companies
in the Biotechnology industry
Industry Median: 7.91 vs CLGN: 4.00

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-01), CollPlant Biotechnologies's stock price is $5.7801. CollPlant Biotechnologies's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.93. Therefore, CollPlant Biotechnologies's PS Ratio for today is 6.20.

CollPlant Biotechnologies EV-to-Revenue Historical Data

The historical data trend for CollPlant Biotechnologies's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CollPlant Biotechnologies EV-to-Revenue Chart

CollPlant Biotechnologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

8.73

222.96

4.53

CollPlant Biotechnologies Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															222.96	85.39	6.87	3.54	4.53

Competitive Comparison of CollPlant Biotechnologies's EV-to-Revenue

For the Biotechnology subindustry, CollPlant Biotechnologies's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CollPlant Biotechnologies's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CollPlant Biotechnologies's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where CollPlant Biotechnologies's EV-to-Revenue falls into.

CollPlant Biotechnologies EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

CollPlant Biotechnologies's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	43.838	/	10.959
	=	4.00

CollPlant Biotechnologies's current Enterprise Value is $43.84 Mil.
CollPlant Biotechnologies's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $10.96 Mil.

CollPlant Biotechnologies (NAS:CLGN) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

CollPlant Biotechnologies's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	5.7801	/	0.933
	=	6.20

CollPlant Biotechnologies's share price for today is $5.7801.
CollPlant Biotechnologies's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.93.

CollPlant Biotechnologies EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of CollPlant Biotechnologies's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

CollPlant Biotechnologies (CollPlant Biotechnologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CollPlant Biotechnologies Ltd (NAS:CLGN) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

CPT:Germany

Address

4 Oppenheimer Street, P.O. Box 4132, Weizmann Science Park, Rehovot, ISR, 7670104

Website

https://www.collplant.com

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The company's revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing.